Carmustine medac (previously Carmustine Obvius) Unione Europea - italiano - EMA (European Medicines Agency)

carmustine medac (previously carmustine obvius)

medac gesellschaft für klinische spezialpräparate mbh - carmustina - hodgkin disease; lymphoma, non-hodgkin - agenti antineoplastici - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).

EMPRESSIN Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

empressin

orpha-devel handels und vertriebs gmbh - vasopressina - vasopressina

Semglee Unione Europea - italiano - EMA (European Medicines Agency)

semglee

viatris limited - insulina glargine - diabete mellito - farmaci usati nel diabete - trattamento del diabete mellito in adulti, adolescenti e bambini dai 2 anni in su.

FLOXATRIL MAX Italia - italiano - Ministero della Salute

floxatril max

virbac - enrofloxacina - enrofloxacina - 100 milligrammi/millilitro (mg/ml), enrofloxacina - 100 mg/ml - enrofloxacin

BICNU Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

bicnu

tillomed italia srl - carmustina - carmustina